LIVN · LivaNova PLC
United States · RS rating 87 · As of 2026-11-03
| Price | 79.90 USD |
|---|---|
| 1-day change | -0.4% |
| RS rating (overall / 1M / 3M / 12M) | 87 / 70 / 72 / 86 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 44 / 54 / 39 |
| Industry group (rank) | Medical-Products (106) |
| EPS growth Q/Q | +14.3% |
| Sales growth Q/Q | +0.9% |
| Distance from 52-week high | +6.4% |
| Market cap (USD) | $3.6B |